Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct 21;7(20):4163-5.
doi: 10.1039/b911483a. Epub 2009 Aug 7.

Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine

Affiliations

Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine

Peter Wipf et al. Org Biomol Chem. .

Abstract

Two novel SF5 analogs of the antimalarial agent mefloquine were synthesized in 5 steps and 10-23% overall yields and found to have improved activity and selectivity against malaria parasites. This work also represents the first report of SF5-substituted quinolines.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mefloquine (1).
Fig. 2
Fig. 2
Electron-density surfaces/electrostatic potential maps calculated with Spartan 08 (HF/6–31G*) for 2 analogs of 1, 4-methyl-8-penta-fluorosulfanyl-2-trifluoromethylquinoline (left) and 4-methyl-2,8-bis-(trifluoromethyl)quinoline (right).
Fig. 3
Fig. 3
Stereoview of the X-ray structure of 3.
Fig. 4
Fig. 4
Structures of trifluoromethylated quinoline methanols 10 and 11 used as references in the biological assays.
Scheme 1
Scheme 1
Synthesis of mefloquine analogs 2 and 3.

References

    1. World Health Organization. The World Health Report. World Heath Organization; Geneva, Switzerland: 1998.
    1. Foley M, Tilley L. Pharmacol Ther. 1998;79:55. - PubMed
    2. Ridley RG. Nature. 2002;415:686. - PubMed
    1. Trenholme GM, Williams RL, Desjardins RE, Frischer H, Carson PE, Rieckmann KH, Canfield CJ. Science. 1975;190:792. - PubMed
    2. Palmer KJ, Holliday SM, Brogden RN. Drugs. 1993;45:430. - PubMed
    3. O’Neill PM, Park BK, Shone AE, Maggs JL, Roberts P, Stocks PA, Biagini GA, Bray PG, Gibbons P, Berry N, Winstanley PA, Mukhtar A, Bonar-Law R, Hindley S, Bambal RB, Davis CB, Bates M, Hart TK, Gresham SL, Lawrence RM, Brigandi RA, Gomez-delas-Heras FM, Gargallo DV, Ward SA. J Med Chem. 2009;52:1408. - PubMed
    1. Tin F, Hlaing N, Lasserre R. Bull WHO. 1982;60:913. - PMC - PubMed
    2. Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, Kern W, Pohle HD. Am J Trop Med Hyg. 1991;45:86. - PubMed
    3. Hennequin C, Bourée P, Bazin N, Bisaro F, Feline A. Arch Intern Med. 1994;154:2360. - PubMed
    4. Schlagenhauf P, Steffen R, Lobel H, Johnson R, Letz R, Tschopp A, Vranjes N, Bergqvist Y, Ericsson O, Hellgren U, Rombo L, Mannino S, Handschin J, Stürchler D. Trop Med Int Health. 1996;1:485. - PubMed
    1. Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Proc Natl Acad Sci U S A. 1989;86:695. - PMC - PubMed
    2. Riffkin CD, Chung R, Wall DM, Zalcberg JR, Cowman AF, Foley M, Tilley L. Biochem Pharmacol. 1996;52:1545. - PubMed
    3. Jones R, Kunsman G, Levine B, Smith M, Stahl C. Forensic Sci Int. 1994;68:29. - PubMed
    4. Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F. Int J Clin Pharmacol Ther. 1999;37:58. - PubMed

MeSH terms